Patient-requested surveillance for suspected acral melanoma: balancing autonomy and clinical risk
Clicks: 6
ID: 323230
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
6 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #28 of 169 articles by views in clinical and experimental dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 169 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
We present an ethical dilemma involving a patient with suspected acral melanoma who requests surveillance rather than the recommended urgent excision biopsy. This raises a conflict between respect for patient autonomy and the need for timely investigation of a potentially serious malignancy. The case explores how clinicians should respond when a capacitous patient declines recommended cancer pathway management.
| Reference Key |
openalex_W7172206251
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sumbel Khan, Neil P Patel |
| Journal | clinical and experimental dermatology |
| Year | 2026 |
| DOI |
10.1093/ced/llag341
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.